BDNF and Huntington disease: Available results from in vitro experiments indicate that the loss of CB1-R in HD would lead to reduced levels of BDNF, which in turn should render striatal cells more vulnerable to mHtt toxicity, possibly through decreases in PGC-1α levels (Laprairie et al., 2013).